Drug Interactions and Side Effects Analysis of Mylotarg and Ampicillin and Levofloxacin and Dexamethasone Tab and Cefepime and Tretinoin and Vancomycin and Allopurinol and Pantoprazole Sodium
>>> Check drugs in a new way
| Report ID | Date of report | Patient age | Patient gender |
| 162016 | Jul, 11, 2006 | 56 | Male |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Mylotarg | gemtuzumab ozogamicin |
Ampicillin | ampicillin/ampicillin trihydrate |
Levofloxacin | levofloxacin |
Dexamethasone Tab | dexamethasone |
Cefepime | cefepime hydrochloride |
Tretinoin | tretinoin |
Vancomycin | vancomycin hydrochloride |
Allopurinol | allopurinol |
Pantoprazole Sodium | pantoprazole sodium |
| Name |
Atelectasis |
Bradycardia |
Brain Oedema |
Cerebral Infarction |
Cerebrovascular Accident |
Concomitant Disease Progression |
Convulsion |
Culture Urine Positive |
Disseminated Intravascular Coagulation |
Enterococcal Infection |
Haematuria |
Hypertension |
Ischaemic Stroke |
Prostate Cancer |
Pulmonary Oedema |
Renal Failure Acute |
Weight Increased |
Results from eHealthMe : 1 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Atelectasis | 1 (100.00%) |
Bradycardia | 1 (100.00%) |
Brain Oedema | 1 (100.00%) |
Cerebral Infarction | 1 (100.00%) |
Cerebrovascular Accident | 1 (100.00%) |
Concomitant Disease Progression | 1 (100.00%) |
Convulsion | 1 (100.00%) |
Culture Urine Positive | 1 (100.00%) |
Disseminated Intravascular Coagulation | 1 (100.00%) |
Enterococcal Infection | 1 (100.00%) |
Haematuria | 1 (100.00%) |
Hypertension | 1 (100.00%) |
Ischaemic Stroke | 1 (100.00%) |
Prostate Cancer | 1 (100.00%) |
Pulmonary Oedema | 1 (100.00%) |
Renal Failure Acute | 1 (100.00%) |
Weight Increased | 1 (100.00%) |
Top 3 (total: 0. Click here to see more) co-used drugs - potential interacting drugs:
Death reported: 0
| Name | Count (% of total reports) |
Ischaemic Stroke | 1 (100.00%) |
Hypertension | 1 (100.00%) |
Haematuria | 1 (100.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
